相关实验视频
Updated: Jun 12, 2025

10:42
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
9.4K
具有抗癌潜力的海洋生物活性,一个叙事审查
Diana Rafieezadeh1, Goli Esfandyari2
1Department of Cellular and Molecular Biology, Razi University Kermanshah, Iran.
International journal of biochemistry and molecular biology
|September 23, 2024
概括
来自鱼,海绵和软体动物的海洋生物活性显示出显著的抗癌潜力. 这些化合物正在开发成为针对各种癌症机制的新疗法.
科学领域:
- 海洋生物学 海洋生物学
- 药理学 药理学 是一个学科.
- 生物化学 生物化学
背景情况:
- 海洋生物是生物活性化合物的丰富来源.
- 海洋生物活性具有多样化的药理活性.
- 几种海洋在临床前和临床癌症研究中表现有前途.
研究的目的:
- 探索具有抗癌潜力的海洋生物活性.
- 确定这些的源和作用机制.
- 评估它们在医学中的治疗前景.
主要方法:
- 隔离和识别来自海洋生物的,如,海绵和软体动物.
- 酶性水解用于从海洋蛋白质中提取.
- 对抗癌细胞的活性的评估和它们的机制的探索 (例如,细胞亡,血管生成).
主要成果:
- 像斯蒂利辛,帕普阿米德,贾斯帕米德,荷莫菲明,阿普利丁和卡哈拉利德F这样的类药物对癌细胞具有强烈的细胞毒性活性.
- 海洋会影响关键的癌症途径,包括亡,微管动力学和血管生成.
- 一些可以针对已知的途径,而另一些则通过新的机制起作用.
结论:
- 来自海洋的生物活性代表了开发新型抗癌药物的有前途来源.
- 对它们的机制和优化的进一步研究可以导致有效的癌症疗法.
- 这些可以为癌症治疗提供多种不同的治疗策略.
更多相关视频
12:14CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
2.6K
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
11.8K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K